Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Fennec Pharmaceuticals Inc. (T.FRX) had Gross Margin of 80.54% for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
-7.82M |
|
-- |
|
-- |
|
-- |
|
-7.10M |
|
-- |
|
-7.82M |
|
-7.82M |
|
-7.82M |
|
-7.82M |
|
-7.82M |
|
-7.82M |
|
-7.10M |
|
-7.07M |
|
27.37M |
|
27.37M |
|
-0.29 |
|
-0.29 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
80.39M |
|
-- |
|
-- |
|
-- |
|
87.44M |
|
-7.05M |
|
-7.05M |
|
-7.05M |
|
27.42M |
|
| Cash Flow Statement Financials | |
38.82M |
|
-- |
|
-1.91M |
|
18.10M |
|
55.01M |
|
36.91M |
|
5.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.80 |
|
-- |
|
-- |
|
1.21 |
|
-5.76 |
|
|
Gross Margin |
80.54% |
-74.59% |
|
-74.59% |
|
-- |
|
-82.23% |
|
-82.23% |
|
38.82M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
1.21 |
|
0.54 |
|
166.58 |
|
110.91% |
|
110.91% |
|
-9.73% |
|
-23.31% |
|
-0.26 |
|
1.42 |
|
1.42 |
|